Oxytetracycline‐induced thrombocytopenic purpura
暂无分享,去创建一个
P. Bierling | F. Bauduer | R. Zittoun | T. Lecompte | B. Rio | C. Lecrubier
[1] A. Marcelli-Barge. Thrombopénies et leucopénies immuno-allergiques d'origine médicamenteuse. , 1989 .
[2] V. Kiefel,et al. Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. , 1987, Blood.
[3] F. Oosterhof,et al. A Simple Immunofluorescence Test for the Detection of Platelet Antibodies , 1978, British journal of haematology.
[4] J. Brouet,et al. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. , 1976, Clinical and experimental immunology.
[5] C. W. Parker,et al. Drug allergy (first of three parts). , 1975, The New England journal of medicine.
[6] N. Kounis. Oxytetracycline-induced thrombocytopenic purpura. , 1975, JAMA.
[7] Rodney Harris,et al. HL-A AND RENAL GRAFT SURVIVAL , 1974 .
[8] H. A. Azar,et al. "Nonsecretory" plasma cell myeloma: observations on seven cases with electron microscopic studies. , 1972, American journal of clinical pathology.
[9] A G BECKETT,et al. Thrombocytopenic purpura associated with oxytetracycline therapy. , 1955, Lancet.
[10] Ackroyd Jf. The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid. , 1949 .
[11] A. Salama,et al. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. , 1990, Transfusion medicine reviews.
[12] J. Ackroyd. The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid. , 1949, Clinical science.